MAGE 2
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
November, 2024
November 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Oct
MAGE 2
Apr 12, 2024, 16:43 |
Drugs
Tanja Obradovic: Exciting new vaccine is about to start Phase III in advanced NSCLC patients that progressed following immunotherapy
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: “Exciting…
All:
1
Posts:
1 - 100
Dr. Richard Pazdur: 25 Years of Transforming Oncology Drug Development at the FDA
New €4.9m Beaumont RCSI Cancer Centre and Irish Cancer Society Partnership to Transform Lung Cancer Care in Ireland
Biden Cancer Moonshot Initiative Awards Over $6 Million to 11 Early-Career Researchers for Innovative Cancer Research
Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More
Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube